Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Amur Minerals ( (GB:CRTX) ).
CRISM Therapeutics Corporation announced an update presentation available on the Investor Meet Company platform, where CEO Andrew Webb discusses the current funding round and the company’s near-term plans. This update, which includes details about a recently announced retail offer, is part of CRISM’s strategy to bolster its market position and operational capabilities.
More about Amur Minerals
CRISM Therapeutics Corporation has developed an innovative drug delivery technology aimed at enhancing the clinical performance of cancer treatments for solid tumors. Their lead product, ChemoSeed, is designed to deliver chemotherapy drugs directly to tumor sites, improving treatment efficacy, particularly in challenging cases like high-grade glioma.
Average Trading Volume: 81,125
Technical Sentiment Signal: Sell
Current Market Cap: £1.83M
For detailed information about CRTX stock, go to TipRanks’ Stock Analysis page.